Pharmacy Grand Rounds
No Gout About It: Updates in Management of Gout

• ACPE Universal Activity Number (UAN): JA0000238-0000-20-028-L01-P
• Session Type: Knowledge-based
• CE Credits: A maximum of 0.75 contact hour (0.075 CEU) for the following: 
  • AAPA Category 1 CME Credits
  • ACPE
  • AMA PRA Category 1 Credits™
  • ANCC

• Session Fee: Free for Mayo Clinic staff

SESSION LOCATIONS

Live Session: (11:00am - 11:45am CST)

Until future notice, learners must watch Pharmacy Grand Rounds live via the web by going to the Video Exchange and selecting “Pharmacy Grand Rounds” in the “Streaming Now” section.

Participants may attend by viewing: Live Webcast
Video Recording - access two weeks after session date

COURSE DESCRIPTION

Gout is the most common form of inflammatory arthritis, affecting about 9.2 million adults in the US. Despite effective and low cost medications to treat gout, adherence to urate lowering therapies remains poor. In May of 2020, The American College of Rheumatology released new guidelines for management of gout. Since the prior 2012 guidelines were published, several clinical trials have been conducted that provide additional evidence regarding the management of gout. This presentation will review the literature leading to these recommendations.

At the conclusion of this knowledge-based CE session, participants should be able to:

• Discuss new guideline recommendations for the management of gout
• Review the literature contributing to the new gout recommendations
• Recognize patients that would benefit from newer gout therapies based on guideline recommendation

Session Announcement

Session Slides

FACULTY INFORMATION

Madison L. Fazio, PharmD
PGY1 Pharmacy Resident
Mayo Clinic Health System - Mankato

Madison received a Doctor of Pharmacy degree from Drake University in Des Moines, IA.  She is a current PGY1 Pharmacy Resident at Mayo Clinic Health System – Mankato with clinical practice interests in ambulatory care, internal medicine and infectious diseases.

DISCLOSURE STATEMENTS

As a provider accredited by Joint Accreditation Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science (Mayo Clinic School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program:

The faculty report the following relationships:

• Madison L. Fazio, PharmD
  • Declares no financial relationships pertinent to this session
  • Declares off-label use of devices and medications will be discussed during this presentation, including:
    • Anakinra
    • Canakinumab

Course Director and Planning Committee Members declare no relevant financial relationship(s) pertinent to this session.  Members include:

• Brenda Amaris
• Mary Ellen Cordes, MS, APRN, CNC, NE-BC
• Michael Huckabee, MPAS, PA-C, PhD
• Wayne (Nick) Nicholson, MD, PharmD, BCPS
• Garrett Schramm, PharmD, BCPS
• Lee Skrupky, PharmD, BCPS